European Association for Hemophilia and Allied Disorders (EAHAD 2026)
3 - 6 February 2026
Mim8 prophylaxis in children with haemophilia A: 52-week efficacy and safety outcomes from FRONTIER3
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.